|
|
 |
|
| | |
| | | | |
organism-gene
|
|
PR:P22105 |
tenascin-X (human)
|
hTNXB
|
"A tenascin-X that is encoded in the genome of human." [PRO:DNx, UniProtKB:P22105]
|
|
|
|
|
|
|
| | | | |
| | |
organism-sequence
|
|
PR:P22105-1 |
tenascin-X isoform h3 (human)
|
hTNXB/iso:h3
|
"A tenascin-X (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P22105-1." [PRO:DNx, UniProtKB:P22105]
|
|
|
|
|
|
|
| | | | |
| | |
organism-sequence
|
|
PR:P22105-2 |
tenascin-X isoform XB-short (human)
|
hTNXB/iso:XB-short
|
"A tenascin-X (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P22105-2." [PRO:DNx, UniProtKB:P22105]
|
|
|
|
|
|
|
| | | | |
| | |
organism-sequence
|
|
PR:P22105-3 |
tenascin-X isoform h4 (human)
|
hTNXB/iso:h4
|
"A tenascin-X (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P22105-3." [PRO:DNx, UniProtKB:P22105]
|
|
|
|
|
|
|
| | | | |
| | |
organism-sequence
|
|
PR:P22105-4 |
tenascin-X isoform h5 (human)
|
hTNXB/iso:h5
|
"A tenascin-X (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P22105-4." [PRO:DNx, UniProtKB:P22105]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056146 |
tenascin-X O-glycosylated 1 (human)
|
hTNXB/OGlyco:1
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-178 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Ser-178, MOD:00002~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056147 |
tenascin-X O-glycosylated 2 (human)
|
hTNXB/OGlyco:2
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-178 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Ser-178, MOD:00002~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056148 |
tenascin-X O-glycosylated 3 (human)
|
hTNXB/OGlyco:3
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-2292 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Ser-2292, MOD:00002~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056149 |
tenascin-X O-glycosylated 4 (human)
|
hTNXB/OGlyco:4
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-2943 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Ser-2943, MOD:00002~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056150 |
tenascin-X O-glycosylated 5 (human)
|
hTNXB/OGlyco:5
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-3923 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Ser-3923, MOD:00002~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056151 |
tenascin-X O-glycosylated 6 (human)
|
hTNXB/OGlyco:6
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-54 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Ser-54, MOD:00002~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056152 |
tenascin-X O-glycosylated 7 (human)
|
hTNXB/OGlyco:7
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-943 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Ser-943, MOD:00002~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056153 |
tenascin-X O-glycosylated 8 (human)
|
hTNXB/OGlyco:8
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-946 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Ser-946, MOD:00002~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056154 |
tenascin-X O-glycosylated 9 (human)
|
hTNXB/OGlyco:9
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Ser-946 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G73004SD. Example: UniProtKB:P22105-3, Ser-946, MOD:00002~GNO:G73004SD." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056155 |
tenascin-X O-glycosylated 10 (human)
|
hTNXB/OGlyco:10
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1180 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-1180, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056156 |
tenascin-X O-glycosylated 11 (human)
|
hTNXB/OGlyco:11
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1364 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-1364, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056157 |
tenascin-X O-glycosylated 12 (human)
|
hTNXB/OGlyco:12
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1469 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22105-3, Thr-1469, MOD:00005~GNO:G29068FM." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056158 |
tenascin-X O-glycosylated 13 (human)
|
hTNXB/OGlyco:13
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1469 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-1469, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056159 |
tenascin-X O-glycosylated 14 (human)
|
hTNXB/OGlyco:14
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1569 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22105-3, Thr-1569, MOD:00005~GNO:G29068FM." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056160 |
tenascin-X O-glycosylated 15 (human)
|
hTNXB/OGlyco:15
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1569 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-1569, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056161 |
tenascin-X O-glycosylated 16 (human)
|
hTNXB/OGlyco:16
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1872 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Thr-1872, MOD:00005~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056162 |
tenascin-X O-glycosylated 17 (human)
|
hTNXB/OGlyco:17
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1873 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-1873, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056163 |
tenascin-X O-glycosylated 18 (human)
|
hTNXB/OGlyco:18
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-1876 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-1876, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056164 |
tenascin-X O-glycosylated 19 (human)
|
hTNXB/OGlyco:19
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2083 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-2083, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056165 |
tenascin-X O-glycosylated 20 (human)
|
hTNXB/OGlyco:20
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2324 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22105-3, Thr-2324, MOD:00005~GNO:G29068FM." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056166 |
tenascin-X O-glycosylated 21 (human)
|
hTNXB/OGlyco:21
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2324 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-2324, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056167 |
tenascin-X O-glycosylated 22 (human)
|
hTNXB/OGlyco:22
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2357 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-2357, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056168 |
tenascin-X O-glycosylated 23 (human)
|
hTNXB/OGlyco:23
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2399 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-2399, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056169 |
tenascin-X O-glycosylated 24 (human)
|
hTNXB/OGlyco:24
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2514 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-2514, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056170 |
tenascin-X O-glycosylated 25 (human)
|
hTNXB/OGlyco:25
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2649 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-2649, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056171 |
tenascin-X O-glycosylated 26 (human)
|
hTNXB/OGlyco:26
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2837 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P22105-3, Thr-2837, MOD:00005~GNO:G58001LT." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056172 |
tenascin-X O-glycosylated 27 (human)
|
hTNXB/OGlyco:27
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2838 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22105-3, Thr-2838, MOD:00005~GNO:G29068FM." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056173 |
tenascin-X O-glycosylated 28 (human)
|
hTNXB/OGlyco:28
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2838 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-2838, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056174 |
tenascin-X O-glycosylated 29 (human)
|
hTNXB/OGlyco:29
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-2944 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-2944, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056175 |
tenascin-X O-glycosylated 30 (human)
|
hTNXB/OGlyco:30
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3052 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-3052, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056176 |
tenascin-X O-glycosylated 31 (human)
|
hTNXB/OGlyco:31
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3054 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22105-3, Thr-3054, MOD:00005~GNO:G29068FM." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056177 |
tenascin-X O-glycosylated 32 (human)
|
hTNXB/OGlyco:32
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3054 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-3054, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056178 |
tenascin-X O-glycosylated 33 (human)
|
hTNXB/OGlyco:33
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3158 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-3158, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056179 |
tenascin-X O-glycosylated 34 (human)
|
hTNXB/OGlyco:34
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3257 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-3257, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056180 |
tenascin-X O-glycosylated 35 (human)
|
hTNXB/OGlyco:35
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3541 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22105-3, Thr-3541, MOD:00005~GNO:G29068FM." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056181 |
tenascin-X O-glycosylated 36 (human)
|
hTNXB/OGlyco:36
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3541 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-3541, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056182 |
tenascin-X O-glycosylated 37 (human)
|
hTNXB/OGlyco:37
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3880 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-3880, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056183 |
tenascin-X O-glycosylated 38 (human)
|
hTNXB/OGlyco:38
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-3922 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Thr-3922, MOD:00005~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056184 |
tenascin-X O-glycosylated 39 (human)
|
hTNXB/OGlyco:39
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-47 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-47, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056185 |
tenascin-X O-glycosylated 40 (human)
|
hTNXB/OGlyco:40
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-83 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-83, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056186 |
tenascin-X O-glycosylated 41 (human)
|
hTNXB/OGlyco:41
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-91 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22105-3, Thr-91, MOD:00005~GNO:G29068FM." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056187 |
tenascin-X O-glycosylated 42 (human)
|
hTNXB/OGlyco:42
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-91 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-91, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056188 |
tenascin-X O-glycosylated 43 (human)
|
hTNXB/OGlyco:43
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-936 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Thr-936, MOD:00005~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056189 |
tenascin-X O-glycosylated 44 (human)
|
hTNXB/OGlyco:44
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-937 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G35029YA. Example: UniProtKB:P22105-3, Thr-937, MOD:00005~GNO:G35029YA." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056190 |
tenascin-X O-glycosylated 45 (human)
|
hTNXB/OGlyco:45
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-937 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-937, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056191 |
tenascin-X O-glycosylated 46 (human)
|
hTNXB/OGlyco:46
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-937 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Thr-937, MOD:00005~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056192 |
tenascin-X O-glycosylated 47 (human)
|
hTNXB/OGlyco:47
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-947 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-947, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056193 |
tenascin-X O-glycosylated 48 (human)
|
hTNXB/OGlyco:48
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-947 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P22105-3, Thr-947, MOD:00005~GNO:G53434XO." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056194 |
tenascin-X O-glycosylated 49 (human)
|
hTNXB/OGlyco:49
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-948 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22105-3, Thr-948, MOD:00005~GNO:G29068FM." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056195 |
tenascin-X O-glycosylated 50 (human)
|
hTNXB/OGlyco:50
|
"A tenascin-X (human) that has been O-glycosylated at the residue equivalent to Thr-948 of the amino acid sequence represented by UniProtKB:P22105-3, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P22105-3, Thr-948, MOD:00005~GNO:G43417UB." [GlyGen:P22105-3, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000062368 |
tenascin-X, signal peptide removed form (human)
|
hTNXB/SigPep-
|
"A tenascin-X (human) that has had the signal peptide removed. Example: UniProtKB:P22105-3, 24-4244." [PRO:DNx, Reactome:R-HSA-2672026]
|
|
|
|
|
